(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

That must mean the equity risk premium’s predictive power lies in earnings yields, and that’s exactly what the data suggest.

On the eve of the NFL playoffs, the oddsmakers have made their thoughts clear: There are five clear Super Bowl contenders, ...

Crop farmers in South Texas are witnessing the future of agriculture unfold with the advent of digital-twin technology.

Top business leaders in the region share what they're watching for growth opportunities in 2025 ... and reveal the pitfalls ...

Nigerians are likely to continue grappling with the high cost of goods and services for some time, as a projection suggested that inflation ...

These are tech expert Marc Salzman's top CES picks for USA TODAY after his hands-on with future gadgets and gear in Las Vegas ...

Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Preliminary ...

Background In a highly competitive market, a plastic parts company leveraged Lean Six Sigma methodologies, particularly ...

The pace of payroll growth is expected to ease again in December after November’s unexpected surge, in keeping with...Læs ...

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- (NYSE American: MTNB) announces that on January 6, 2025, it received a ...

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class ...